ArticleBMC medicine2024

ANXA4 restricts HBV replication by inhibiting autophagic degradation of MCM2 in chronic hepatitis B.

Luo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.